Skip to content

Positioning in Wheelchair Bound Patients

Evaluation of Actions to Improve Positioning in Wheelchaire Bound Patients at Risk of Slipping : Pilot Study

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05653089
Acronym
AAPO'G
Enrollment
30
Registered
2022-12-16
Start date
2023-10-01
Completion date
2023-12-22
Last updated
2023-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurological Disease

Keywords

wheelchair, seating discomfort

Brief summary

The choice of the most suitable chair as well as the improvement of the patient's positioning on this wheelchair is important to limit the discomfort, to prevent the risks of bedsores, the pains related to prolonged sitting and finally to support the interaction of the patient with its environment. The goal of this prospective, longitudinale, monocentric study is to evaluate the impact of standardized positioning in wheelchair-bound patients at risk of slipping. The main questions on the positioning actions are: * their actions impact of positioning actions on shear forces * their impact on sliding in the chair * their impact on the feeling of discomfort in the chair * their impact on the caregivers' feelings about the patient's difficulties (eating, transfers, sliding) Participation in this study will involve an increase in the number of transfers required for shear sheet placement and removal, as well as the time required for ischial measurement and the time to complete the (Tool for Assessing Wheelchair disComfort) TAWC questionnaire.

Interventions

PROCEDUREChoice and adjustment of the wheelchair according to the patient's needs

After a personalized analysis of the patient and his needs, the occupational therapists define the equipment necessary for the good positioning of the patient: * Choice and adjustments of the wheelchair * Choice and adjustments of the wheelchair/patient interface

Sponsors

GHICL
CollaboratorUNKNOWN
FondationbHopale
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patient hospitalized for a minimum of 9 days (minimum 48-hour reflection period after information) * Patient aged between 18 and 80 years, * Patient with a sitting time in a wheelchair \> or equal to 1 hour, * Patient with a neurological condition : multiple sclerosis, stroke, spinal cord injury, Parkinson disease, neurodegenerative diseases... * Patient informed of the study and having given his written consent, Non inclusion Criteria: * Cognitive disorders that do not allow the understanding of instructions * Patient with a pressure sore * Pregnant or breastfeeding woman * Patient under legal protection

Design outcomes

Primary

MeasureTime frameDescription
Evolution of shear measurement with the Shear® sensorDay 0 therefore before the implementation of the positioning actions then at Day 1 and Day 7Shear will be measured over a period of one hour (shear evolution over one hour), during which the patient will follow a standardized activity program.

Secondary

MeasureTime frameDescription
Comparison of the sliding distanceDay 0 therefore before the implementation of the positioning actions then at Day 1 and Day 7The sliding distance is measured by the position of the ischiums. It is the difference between the position measured before and after 1 hour of standardized activities.
Evolution of the score on the TAWC scaleDay 0 therefore before the implementation of the positioning actions then at Day 7The TAWC (Tool for Assessing Wheelchair discomfort) scale assesses 2 discomfort scores: * an assessment of general discomfort, based on 13 items scored on 7 points * an evaluation of the intensity of the discomfort, based on 9 items from 0 to 10.
Evolution of the caregiver questionnaire score (Likert scale)Day 0 therefore before the implementation of the positioning actions then at Day 7

Countries

France

Contacts

Primary ContactMarine Deseur
marine.deseur@fondation-hopale.org+33362882780
Backup ContactJulien PAGER
julien.pager@fondation-hopale.org

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026